OTX015_104

• Research type

  Research Study

• Full title

  A phase I, dose-finding study of the bromodomain (Brd) inhibitor OTX015 in haematological malignancies

• IRAS ID

  138999

• Contact name

  David Cunningham

• Contact email

  ProfDavid.Cunningham@rmh.nhs.uk

• Sponsor organisation

  ONCOETHIX

• Eudract number

  2012-003380-22

• Clinicaltrials.gov Identifier

  NCT01713582

• REC name

  London - Central Research Ethics Committee

• REC reference

  14/LO/0092

• Date of REC Opinion

  10 Apr 2014

• REC opinion

  Further Information Favourable Opinion